Cargando…

Advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities

Sarcopenic muscular degeneration has been consistently identified as an independent risk factor for mortality in aging populations. Recent investigations have realized the quantitative potential of computed tomography (CT) image analysis to describe skeletal muscle volume and composition; however, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Edmunds, Kyle, Gíslason, Magnús, Sigurðsson, Sigurður, Guðnason, Vilmundur, Harris, Tamara, Carraro, Ugo, Gargiulo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841751/
https://www.ncbi.nlm.nih.gov/pubmed/29513690
http://dx.doi.org/10.1371/journal.pone.0193241
_version_ 1783304789779546112
author Edmunds, Kyle
Gíslason, Magnús
Sigurðsson, Sigurður
Guðnason, Vilmundur
Harris, Tamara
Carraro, Ugo
Gargiulo, Paolo
author_facet Edmunds, Kyle
Gíslason, Magnús
Sigurðsson, Sigurður
Guðnason, Vilmundur
Harris, Tamara
Carraro, Ugo
Gargiulo, Paolo
author_sort Edmunds, Kyle
collection PubMed
description Sarcopenic muscular degeneration has been consistently identified as an independent risk factor for mortality in aging populations. Recent investigations have realized the quantitative potential of computed tomography (CT) image analysis to describe skeletal muscle volume and composition; however, the optimum approach to assessing these data remains debated. Current literature reports average Hounsfield unit (HU) values and/or segmented soft tissue cross-sectional areas to investigate muscle quality. However, standardized methods for CT analyses and their utility as a comorbidity index remain undefined, and no existing studies compare these methods to the assessment of entire radiodensitometric distributions. The primary aim of this study was to present a comparison of nonlinear trimodal regression analysis (NTRA) parameters of entire radiodensitometric muscle distributions against extant CT metrics and their correlation with lower extremity function (LEF) biometrics (normal/fast gait speed, timed up-and-go, and isometric leg strength) and biochemical and nutritional parameters, such as total solubilized cholesterol (SCHOL) and body mass index (BMI). Data were obtained from 3,162 subjects, aged 66–96 years, from the population-based AGES-Reykjavik Study. 1-D k-means clustering was employed to discretize each biometric and comorbidity dataset into twelve subpopulations, in accordance with Sturges’ Formula for Class Selection. Dataset linear regressions were performed against eleven NTRA distribution parameters and standard CT analyses (fat/muscle cross-sectional area and average HU value). Parameters from NTRA and CT standards were analogously assembled by age and sex. Analysis of specific NTRA parameters with standard CT results showed linear correlation coefficients greater than 0.85, but multiple regression analysis of correlative NTRA parameters yielded a correlation coefficient of 0.99 (P<0.005). These results highlight the specificities of each muscle quality metric to LEF biometrics, SCHOL, and BMI, and particularly highlight the value of the connective tissue regime in this regard.
format Online
Article
Text
id pubmed-5841751
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58417512018-03-23 Advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities Edmunds, Kyle Gíslason, Magnús Sigurðsson, Sigurður Guðnason, Vilmundur Harris, Tamara Carraro, Ugo Gargiulo, Paolo PLoS One Research Article Sarcopenic muscular degeneration has been consistently identified as an independent risk factor for mortality in aging populations. Recent investigations have realized the quantitative potential of computed tomography (CT) image analysis to describe skeletal muscle volume and composition; however, the optimum approach to assessing these data remains debated. Current literature reports average Hounsfield unit (HU) values and/or segmented soft tissue cross-sectional areas to investigate muscle quality. However, standardized methods for CT analyses and their utility as a comorbidity index remain undefined, and no existing studies compare these methods to the assessment of entire radiodensitometric distributions. The primary aim of this study was to present a comparison of nonlinear trimodal regression analysis (NTRA) parameters of entire radiodensitometric muscle distributions against extant CT metrics and their correlation with lower extremity function (LEF) biometrics (normal/fast gait speed, timed up-and-go, and isometric leg strength) and biochemical and nutritional parameters, such as total solubilized cholesterol (SCHOL) and body mass index (BMI). Data were obtained from 3,162 subjects, aged 66–96 years, from the population-based AGES-Reykjavik Study. 1-D k-means clustering was employed to discretize each biometric and comorbidity dataset into twelve subpopulations, in accordance with Sturges’ Formula for Class Selection. Dataset linear regressions were performed against eleven NTRA distribution parameters and standard CT analyses (fat/muscle cross-sectional area and average HU value). Parameters from NTRA and CT standards were analogously assembled by age and sex. Analysis of specific NTRA parameters with standard CT results showed linear correlation coefficients greater than 0.85, but multiple regression analysis of correlative NTRA parameters yielded a correlation coefficient of 0.99 (P<0.005). These results highlight the specificities of each muscle quality metric to LEF biometrics, SCHOL, and BMI, and particularly highlight the value of the connective tissue regime in this regard. Public Library of Science 2018-03-07 /pmc/articles/PMC5841751/ /pubmed/29513690 http://dx.doi.org/10.1371/journal.pone.0193241 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Edmunds, Kyle
Gíslason, Magnús
Sigurðsson, Sigurður
Guðnason, Vilmundur
Harris, Tamara
Carraro, Ugo
Gargiulo, Paolo
Advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities
title Advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities
title_full Advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities
title_fullStr Advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities
title_full_unstemmed Advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities
title_short Advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities
title_sort advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841751/
https://www.ncbi.nlm.nih.gov/pubmed/29513690
http://dx.doi.org/10.1371/journal.pone.0193241
work_keys_str_mv AT edmundskyle advancedquantitativemethodsincorrelatingsarcopenicmuscledegenerationwithlowerextremityfunctionbiometricsandcomorbidities
AT gislasonmagnus advancedquantitativemethodsincorrelatingsarcopenicmuscledegenerationwithlowerextremityfunctionbiometricsandcomorbidities
AT sigurðssonsigurður advancedquantitativemethodsincorrelatingsarcopenicmuscledegenerationwithlowerextremityfunctionbiometricsandcomorbidities
AT guðnasonvilmundur advancedquantitativemethodsincorrelatingsarcopenicmuscledegenerationwithlowerextremityfunctionbiometricsandcomorbidities
AT harristamara advancedquantitativemethodsincorrelatingsarcopenicmuscledegenerationwithlowerextremityfunctionbiometricsandcomorbidities
AT carrarougo advancedquantitativemethodsincorrelatingsarcopenicmuscledegenerationwithlowerextremityfunctionbiometricsandcomorbidities
AT gargiulopaolo advancedquantitativemethodsincorrelatingsarcopenicmuscledegenerationwithlowerextremityfunctionbiometricsandcomorbidities